Skandinaviska Enskilda Banken (SEB)’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Hold |
14,333
| – | – | 0.01% | 508 |
|
|
2025
Q1 | $3.21M | Hold |
14,333
| – | – | 0.02% | 501 |
|
|
2024
Q4 | $4.71M | Sell |
14,333
-596
| -4% | -$196K | 0.02% | 423 |
|
|
2024
Q3 | $4.48M | Sell |
14,929
-700
| -4% | -$210K | 0.02% | 431 |
|
|
2024
Q2 | $5.15M | Buy |
15,629
+1,401
| +10% | +$461K | 0.02% | 370 |
|
|
2024
Q1 | $5.63M | Sell |
14,228
-1,145
| -7% | -$453K | 0.03% | 379 |
|
|
2023
Q4 | $5.41M | Sell |
15,373
-21,786
| -59% | -$7.67M | 0.03% | 370 |
|
|
2023
Q3 | $13.9M | Buy |
37,159
+23,207
| +166% | +$8.71M | 0.09% | 201 |
|
|
2023
Q2 | $5.34M | Buy |
13,952
+1,477
| +12% | +$565K | 0.04% | 375 |
|
|
2023
Q1 | $4.32M | Sell |
12,475
-123
| -1% | -$42.6K | 0.03% | 390 |
|
|
2022
Q4 | $2.97M | Buy |
12,598
+841
| +7% | +$198K | 0.02% | 454 |
|
|
2022
Q3 | $2.89M | Buy |
11,757
+310
| +3% | +$76.3K | 0.02% | 463 |
|
|
2022
Q2 | $3.46M | Sell |
11,447
-1,079
| -9% | -$326K | 0.03% | 437 |
|
|
2022
Q1 | $5.15M | Sell |
12,526
-1,862
| -13% | -$765K | 0.03% | 386 |
|
|
2021
Q4 | $6.78M | Buy |
14,388
+1,025
| +8% | +$483K | 0.03% | 361 |
|
|
2021
Q3 | $5.67M | Sell |
13,363
-65,661
| -83% | -$27.9M | 0.03% | 388 |
|
|
2021
Q2 | $28.4M | Sell |
79,024
-829
| -1% | -$298K | 0.17% | 128 |
|
|
2021
Q1 | $22.5M | Sell |
79,853
-89,678
| -53% | -$25.3M | 0.15% | 142 |
|
|
2020
Q4 | $48M | Sell |
169,531
-17,097
| -9% | -$4.84M | 0.33% | 74 |
|
|
2020
Q3 | $51.3M | Buy |
186,628
+9,688
| +5% | +$2.66M | 0.38% | 62 |
|
|
2020
Q2 | $40.2M | Buy |
176,940
+131,800
| +292% | +$29.9M | 0.32% | 68 |
|
|
2020
Q1 | $6.87M | Buy |
45,140
+34,787
| +336% | +$5.3M | 0.07% | 238 |
|
|
2019
Q4 | $1.56M | Buy |
+10,353
| New | +$1.56M | 0.01% | 621 |
|